{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:15:03Z","timestamp":1785813303318,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370220"],"award-info":[{"award-number":["82370220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200187"],"award-info":[{"award-number":["82200187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41375-025-02673-9","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:03:36Z","timestamp":1751256216000},"page":"1871-1882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-0768","authenticated-orcid":false,"given":"Moran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3410-7000","authenticated-orcid":false,"given":"Donald","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-3062","authenticated-orcid":false,"given":"Linghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruowen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-5894","authenticated-orcid":false,"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-4568","authenticated-orcid":false,"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401:2073\u201386.","journal-title":"Lancet"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","volume":"125","author":"S Sriskanthadevan","year":"2015","unstructured":"Sriskanthadevan S, Jeyaraju DV, Chung TE, Prabha S, Xu W, Skrtic M, et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood. 2015;125:2120\u201330.","journal-title":"Blood"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018;24:1036\u201346.","journal-title":"Nat Med"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nm.4283","volume":"23","author":"N Fenouille","year":"2017","unstructured":"Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, et al. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nat Med. 2017;23:301\u201313.","journal-title":"Nat Med"},{"key":"2673_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500\u20134.","journal-title":"Nature"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2017-12-820035","volume":"131","author":"P Gallipoli","year":"2018","unstructured":"Gallipoli P, Giotopoulos G, Tzelepis K, Costa ASH, Vohra S, Medina-Perez P, et al. Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood. 2018;131:1639\u201353.","journal-title":"Blood"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M Skrti\u0107","year":"2011","unstructured":"Skrti\u0107 M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2011;20:674\u201388.","journal-title":"Cancer Cell"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"E6669","DOI":"10.1073\/pnas.1603876113","volume":"113","author":"MA Gregory","year":"2016","unstructured":"Gregory MA, D\u2019Alessandro A, Alvarez-Calderon F, Kim J, Nemkov T, Adane B, et al. ATM\/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proc Natl Acad Sci USA. 2016;113:E6669\u2013E6678.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exphem.2017.09.007","volume":"58","author":"MA Gregory","year":"2018","unstructured":"Gregory MA, Nemkov T, Reisz JA, Zaberezhnyy V, Hansen KC, D\u2019Alessandro A, et al. Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia. Exp Hematol. 2018;58:52\u201358.","journal-title":"Exp Hematol"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329\u201341.","journal-title":"Cell Stem Cell"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrc3340","volume":"12","author":"A Chiarugi","year":"2012","unstructured":"Chiarugi A, D\u00f6lle C, Felici R, Ziegler M. The NAD metabolome-a key determinant of cancer cell biology. Nat Rev Cancer. 2012;12:741\u201352.","journal-title":"Nat Rev Cancer"},{"key":"2673_CR12","doi-asserted-by":"crossref","unstructured":"Jones CL, Stevens BM, Pollyea DA, Culp-Hill R, Reisz JA, Nemkov T, et al. Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells. Cell Stem Cell. 2020;27:748\u201364","DOI":"10.1016\/j.stem.2020.07.021"},{"key":"2673_CR13","doi-asserted-by":"crossref","unstructured":"Nakagawa T, Guarente L. SnapShot: sirtuins, NAD, and aging. Cell Metab. 2014;20:192\u2013e1.","DOI":"10.1016\/j.cmet.2014.06.001"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, Chhabra G, Ndiaye MA, Garcia-Peterson LM, Mack NJ, Ahmad N. The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal. 2018;28:643\u201361.","journal-title":"Antioxid Redox Signal"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nm.3438","volume":"20","author":"L Guarente","year":"2014","unstructured":"Guarente L. The many faces of sirtuins: sirtuins and the Warburg effect. Nat Med. 2014;20:24\u201325.","journal-title":"Nat Med"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"107748","DOI":"10.1016\/j.pharmthera.2020.107748","volume":"221","author":"M Aventaggiato","year":"2021","unstructured":"Aventaggiato M, Vernucci E, Barreca F, Russo MA, Tafani M. Sirtuins\u2019 control of autophagy and mitophagy in cancer. Pharmacol Ther. 2021;221:107748.","journal-title":"Pharmacol Ther"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021;6:2.","journal-title":"Signal Transduct Target Ther"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","volume":"124","author":"D Sasca","year":"2014","unstructured":"Sasca D, H\u00e4hnel PS, Szybinski J, Khawaja K, Kriege O, Pante SV, et al. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 2014;124:121\u201333.","journal-title":"Blood"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, Osdal T, Ho Y, Chun S, McDonald T, Agarwal P, et al. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell. 2014;15:431\u201346.","journal-title":"Cell Stem Cell"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.stem.2014.09.006","volume":"15","author":"BB Zeisig","year":"2014","unstructured":"Zeisig BB, So CWE. A knockout combo: eradicating AML stem cells with TKI plus SIRT1 inhibition. Cell Stem Cell. 2014;15:395\u20137.","journal-title":"Cell Stem Cell"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3324\/haematol.2011.055236","volume":"97","author":"L Dan","year":"2012","unstructured":"Dan L, Klimenkova O, Klimiankou M, Klusman J-H, van den Heuvel-Eibrink MM, Reinhardt D, et al. The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica. 2012;97:551\u20139.","journal-title":"Haematologica"},{"key":"2673_CR22","doi-asserted-by":"crossref","unstructured":"Zhang Y, Shen Y, Wei W, Wang W, Jiang D, Ren Y, et al. Dysregulation of SIRT3 SUMOylation confers AML chemoresistance via controlling HES1-dependent fatty acid oxidation. Int J Mol Sci. 2022;23:8282.","DOI":"10.3390\/ijms23158282"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-20-3724","volume":"27","author":"P Zhang","year":"2021","unstructured":"Zhang P, Brinton LT, Williams K, Sher S, Orwick S, Tzung-Huei L, et al. Targeting DNA damage repair functions of two histone deacetylases, HDAC8 and SIRT6, sensitizes acute myeloid leukemia to NAMPT inhibition. Clin Cancer Res Off J Am Assoc Cancer Res. 2021;27:2352\u201366.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2673_CR24","doi-asserted-by":"crossref","unstructured":"Shi X, Jiang Y, Kitano A, Hu T, Murdaugh RL, Li Y, et al. Nuclear NAD+ homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells. Sci Adv. 2021;7:eabf3895.","DOI":"10.1126\/sciadv.abf3895"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.molcel.2013.06.001","volume":"50","author":"J Park","year":"2013","unstructured":"Park J, Chen Y, Tishkoff DX, Peng C, Tan M, Dai L, et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell. 2013;50:919\u201330.","journal-title":"Mol Cell"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2014.03.014","volume":"19","author":"M Tan","year":"2014","unstructured":"Tan M, Peng C, Anderson KA, Chhoy P, Xie Z, Dai L, et al. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab. 2014;19:605\u201317.","journal-title":"Cell Metab"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.1207861","volume":"334","author":"J Du","year":"2011","unstructured":"Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science. 2011;334:806\u20139.","journal-title":"Science"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2013.11.013","volume":"18","author":"MJ Rardin","year":"2013","unstructured":"Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR, et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 2013;18:920\u201333.","journal-title":"Cell Metab"},{"key":"2673_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.molcel.2015.05.022","volume":"59","author":"Y Nishida","year":"2015","unstructured":"Nishida Y, Rardin MJ, Carrico C, He W, Sahu AK, Gut P, et al. SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol Cell. 2015;59:321\u201332.","journal-title":"Mol Cell"},{"key":"2673_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/ars.2017.7264","volume":"28","author":"LR Bringman-Rodenbarger","year":"2018","unstructured":"Bringman-Rodenbarger LR, Guo AH, Lyssiotis CA, Lombard DB. Emerging roles for SIRT5 in metabolism and cancer. Antioxid Redox Signal. 2018;28:677\u201390.","journal-title":"Antioxid Redox Signal"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","volume":"27","author":"C Carrico","year":"2018","unstructured":"Carrico C, Meyer JG, He W, Gibson BW, Verdin E. The mitochondrial acylome emerges: proteomics, regulation by sirtuins, and metabolic and disease implications. Cell Metab. 2018;27:497\u2013512.","journal-title":"Cell Metab"},{"key":"2673_CR32","doi-asserted-by":"crossref","unstructured":"Wang G, Meyer JG, Cai W, Softic S, Li ME, Verdin E, et al. Regulation of UCP1 and mitochondrial metabolism in brown adipose tissue by reversible succinylation. Mol Cell. 2019;74:844\u201357.e7.","DOI":"10.1016\/j.molcel.2019.03.021"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"19767","DOI":"10.1074\/jbc.M117.809897","volume":"292","author":"KA Hershberger","year":"2017","unstructured":"Hershberger KA, Abraham DM, Martin AS, Mao L, Liu J, Gu H, et al. Sirtuin 5 is required for mouse survival in response to cardiac pressure overload. J Biol Chem. 2017;292:19767\u201381.","journal-title":"J Biol Chem"},{"key":"2673_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbr.2014.12.035","volume":"281","author":"L Liu","year":"2015","unstructured":"Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson\u2019s disease. Behav Brain Res. 2015;281:215\u201321.","journal-title":"Behav Brain Res"},{"key":"2673_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/2643-3230.BCD-20-0168","volume":"2","author":"D Yan","year":"2021","unstructured":"Yan D, Franzini A, Pomicter AD, Halverson BJ, Antelope O, Mason CC, et al. Sirt5 is a druggable metabolic vulnerability in acute myeloid leukemia. Blood Cancer Discov. 2021;2:266\u201387.","journal-title":"Blood Cancer Discov"},{"key":"2673_CR36","doi-asserted-by":"crossref","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34:724\u201340.e4.","DOI":"10.1016\/j.ccell.2018.10.005"},{"key":"2673_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Investig. 2010;120:142\u201356.","journal-title":"J Clin Investig"},{"key":"2673_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-021-00578-4","volume":"6","author":"R Zhu","year":"2021","unstructured":"Zhu R, Li L, Nguyen B, Seo J, Wu M, Seale T, et al. FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3\/ITD acute leukemia cells through BIM activation. Signal Transduct Target Ther. 2021;6:186.","journal-title":"Signal Transduct Target Ther"},{"key":"2673_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush LI, Mitchell A, Heisler L, Abelson S, Ng SWK, Trotman-Grant A, et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature. 2017;547:104\u20138.","journal-title":"Nature"},{"key":"2673_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","volume":"155","author":"S Cogliati","year":"2013","unstructured":"Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155:160\u201371.","journal-title":"Cell"},{"key":"2673_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0116","volume":"350","author":"T Wai","year":"2015","unstructured":"Wai T, Garc\u00eda-Prieto J, Baker MJ, Merkwirth C, Benit P, Rustin P, et al. Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science. 2015;350:aad0116.","journal-title":"Science"},{"key":"2673_CR42","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714\u201331.","journal-title":"Circulation"},{"key":"2673_CR43","doi-asserted-by":"publisher","first-page":"M111.012658","DOI":"10.1074\/mcp.M111.012658","volume":"10","author":"C Peng","year":"2011","unstructured":"Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M, et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteom. 2011;10:M111.012658.","journal-title":"Mol Cell Proteom"},{"key":"2673_CR44","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ymeth.2005.03.004","volume":"36","author":"BJ North","year":"2005","unstructured":"North BJ, Schwer B, Ahuja N, Marshall B, Verdin E. Preparation of enzymatically active recombinant class III protein deacetylases. Methods. 2005;36:338\u201345.","journal-title":"Methods"},{"key":"2673_CR45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41419-020-02867-2","volume":"11","author":"A Roca-Portoles","year":"2020","unstructured":"Roca-Portoles A, Rodriguez-Blanco G, Sumpton D, Cloix C, Mullin M, Mackay GM, et al. Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell Death Dis. 2020;11:616.","journal-title":"Cell Death Dis"},{"key":"2673_CR46","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1073\/pnas.1519858113","volume":"113","author":"S Sadhukhan","year":"2016","unstructured":"Sadhukhan S, Liu X, Ryu D, Nelson OD, Stupinski JA, Li Z, et al. Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. Proc Natl Acad Sci USA. 2016;113:4320\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2673_CR47","doi-asserted-by":"crossref","unstructured":"Chi Z, Chen S, Xu T, Zhen W, Yu W, Jiang D, et al. Histone deacetylase 3 couples mitochondria to drive IL-1\u03b2-dependent inflammation by configuring fatty acid oxidation. Mol Cell. 2020;80:43\u201358.e7.","DOI":"10.1016\/j.molcel.2020.08.015"},{"key":"2673_CR48","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","volume":"22","author":"X Niu","year":"2016","unstructured":"Niu X, Zhao J, Ma J, Xie C, Edwards H, Wang G, et al. Binding of released bim to Mcl-1 is a mechanism of intrinsic resistance to ABT-199 which can be overcome by combination with daunorubicin or cytarabine in AML cells. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:4440\u201351.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2673_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3324\/haematol.2020.260331","volume":"107","author":"BZ Carter","year":"2022","unstructured":"Carter BZ, Mak PY, Tao W, Warmoes M, Lorenzi PL, Mak D, et al. Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition. Haematologica. 2022;107:58\u201376.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02673-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:08:57Z","timestamp":1757207337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02673-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02673-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human samples were collected under a protocol approved by the Institutional Review Board of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (permit number 0986-01). All animal procedures were conducted in accordance with the policies of the Institutional Animal Care and Use Committee of Tongji Medical College (permit number 3391). This study was conducted in accordance with the Declaration of Helsinki. All patients provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}